TLL1 rs17047200 Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C Reply

被引：0
|
作者：
Matsuura, Kentaro [1 ]
Kurosaki, Masayuki [2 ]
Tanaka, Yasuhito [3 ,4 ]
机构：
[1] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi, Japan
[2] Musashino Red Cross Hosp, Div Gastroenterol & Hepatol, Musashino, Tokyo, Japan
[3] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan
[4] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan
来源：
GASTROENTEROLOGY | 2017年 / 153卷 / 05期
关键词：
D O I：
10.1053/j.gastro.2017.10.004
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1449 / 1450
页数：3
相关论文
共 50 条
  • [31] Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C
    Simon, Tracey G.
    King, Lindsay Y.
    Zheng, Hui
    Chung, Raymond T.
    JOURNAL OF HEPATOLOGY, 2015, 62 (01) : 18 - 23
  • [32] HLA class 1 allelic diversity and progression of fibrosis in chronic hepatitis C patients.
    Patel, K
    Norris, S
    Clare, M
    Pianko, S
    Heaton, S
    Feng, A
    Blatt, LM
    Koziol, J
    Conrad, A
    McHutchison, JG
    HEPATOLOGY, 2002, 36 (04) : 273A - 273A
  • [33] Genotype 1 is associated with a slower progression of fibrosis in untreated patients with mild chronic hepatitis C
    Marcellin, P
    Akremi, R
    Cazals, D
    Boyer, N
    Auperin, A
    Vidaud, D
    Degott, C
    JOURNAL OF HEPATOLOGY, 2001, 34 : 159 - 159
  • [34] Daily cannabis smoking as a risk factor for fibrosis progression in chronic hepatitis C
    Hezode, C
    Roudot-Thoraval, F
    Grenard, P
    Julien, B
    Zafrani, ES
    Dhumeaux, D
    Lotersztajn, S
    Mallat, A
    HEPATOLOGY, 2004, 40 (04) : 192A - 192A
  • [35] A cirrhosis risk score identifies those chronic hepatitis C infected patients presenting with no liver fibrosis that are at high risk for fibrosis progression
    Young, Bradford
    Gerotto, Martina
    Morcolongo, Moira
    Dal Pero, Francesca
    Lagier, Robert
    Rowland, Charles
    Sebastiani, Giodo
    Alberti, Alfredo
    Alameda, Celera
    HEPATOLOGY, 2007, 46 (04) : 442A - 443A
  • [36] The Cirrhosis Risk Score Predicts Liver Fibrosis Progression in Patients with Initially Mild Chronic Hepatitis C
    Pradat, Pierre
    Trepo, Eric
    Potthoff, Andrej
    Bakshi, Rakesh
    Young, Bradford
    Trepo, Christian
    Lagier, Robert
    Moreno, Christophe
    Lemmers, Arnaud
    Gustot, Thierry
    Degre, Delphine
    Adler, Michael
    Wedemeyer, Heiner
    HEPATOLOGY, 2010, 51 (01) : 356 - 357
  • [37] Role of CYP2D6 polymorphism in predicting liver fibrosis progression rate in Caucasian patients with chronic hepatitis C
    Fishman, S
    Lurie, Y
    Peretz, H
    Morad, T
    Grynberg, E
    Blendis, LM
    Leshno, M
    Brazowski, E
    Rosner, G
    Halpern, Z
    Oren, R
    LIVER INTERNATIONAL, 2006, 26 (03) : 279 - 284
  • [38] STAGE-SPECIFIC FIBROSIS PROGRESSION IN PATIENTS TRANSPLANTED FOR CHRONIC HEPATITIS C
    Asrani, Sumeet K.
    Pedersen, Rachel
    Sanderson, Schuyler O.
    Charlton, Michael R.
    Schneekloth, Terry
    Rosen, Charles B.
    Therneau, Terry M.
    Kim, W. Ray
    LIVER TRANSPLANTATION, 2009, 15 (07) : S95 - S95
  • [39] Progression of initially mild hepatic fibrosis in patients with chronic hepatitis C infection
    Williams, M. J.
    Lang-Lenton, M.
    JOURNAL OF VIRAL HEPATITIS, 2011, 18 (01) : 17 - 22
  • [40] Steatosis accelerates fibrosis progression rates in patients with chronic hepatitis C.
    Patton, HM
    Behling, C
    Patel, K
    Pockros, PJ
    Heaton, S
    Blatt, LM
    McHutchison, JG
    HEPATOLOGY, 2002, 36 (04) : 349A - 349A
12345